The role of CPET for the assessment of patients with transthyretin amyloid cardiomyopathy

17 May 2025 (11:00 - 11:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Debora Da Silva Correia

Hospital Santa Cruz, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail

Comparison of inferior vena cava wall thickness in patients with cardiac amyloidosis versus hypertrophic cardiomyopathy, a new diagnostic tool

Doctor T. Li (Singapore, SG)

Abstract Slides Video

Presentation thumbnail

Automated detection of amyloid birefringence by digital pathology in endomyocardial biopsies

Doctor A. Aimo (Pisa, IT)

Abstract Slides Video

Presentation thumbnail

Simple and specific prediction of the final diagnosis in patients with suspected amyloid cardiomyopathy and indication to tissue biopsy

Doctor A. Aimo (Pisa, IT)

Abstract Slides Video

Presentation thumbnail

Clinical implications of cardiac implantable electronic devices in ATTR cardiomyopathy

Doctor R. Saro (Fuerth, DE) Doctor M. Merlo (Trieste, IT)

Abstract Slides Video

Presentation thumbnail

Evolving disease characteristics in cardiac amyloidosis: real-world data from a tertiary referral center

Doctor P. Zwetsloot (Rotterdam, NL)

Abstract Slides Video

Access the full session

Session thumbnail

Phenotyping of amyloidosis

The Event

Event poster

Heart Failure 2025

17 May 2025 11:00 CET

You may be interested in

Congress Presentation

Transthyretin amyloid cardiomyopathy (ATTR-CM): a potential role for cardiopulmonary exercise testing

Congress Presentation

Cardiopulmonary exercise testing as a novel endpoint in clinical trials on ATTR amyloid cardiomyopathy

Congress Presentation

Assessing functional capacity in patients with ATTR-CM: the role of CPET and 6MWT

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources